search
Back to results

Electro-thumbtack Needle Therapy for Chronic Neck Pain

Primary Purpose

Neck Pain

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Electro-thumbtack Needle Therapy
Sham electro-thumbtack needle therapy
Sponsored by
Shi Hangyu
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Neck Pain

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Diagnosed with neck pain with headaches or neck pain with movement coordination impairments according to the Orthopaedic Section of the American Physical Therapy Association (APTA);
  2. Aaged 18-65 years;
  3. History of neck pain for at least 3 months;
  4. A score of ≥4 in Numerical Rating Scale for neck pain (NRS-NP) assessing the average neck pain intensity over last 7 days until the day of recruitment.

Exclusion Criteria:

  1. Diagnosed with neck pain with mobility deficits or neck pain with radiating pain according to the Orthopaedic Section, APTA;
  2. Known specific reason leading to neck pain such as tumor, immune disease, endocrine and metabolic disorders, neurological abnormalities, cervical vertebra fracture, cervical dislocation;
  3. Acute neck pain or neck pain with radiating pain or upper limb symptoms;
  4. Neck pain with sensory or motor disturbance;
  5. Prior cervical spine surgery or congenital abnormalities;
  6. Experiencing medical dispute litigation;
  7. Have received acupuncture in last 30 days;
  8. In need of analgesic, muscle relaxant, hormones, or bearing greater pain from another area;
  9. Allergic to metal or adhesive tape, or carrying cardiac pacemaker, or skin damaged at selected acupoints;
  10. Disable to communicate or critically ill;
  11. Drug or alcohol dependent;
  12. Currently or planning to be pregnant.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Sham Comparator

    Arm Label

    Electro-thumbtack Needle Therapy (ETN) group

    Sham Electro-thumbtack Needle Therapy (ETN) group

    Arm Description

    Electro-thumbtack needles (0.25×2 mm) will be inserted into acupoints of Dazhui (GV14), bilateral Wangu (GB12), bilateral cervical Jiaji (at C4 and C6 level), two Ashi points and bilateral Houxi (SI3) after sterilization. Then apply the gel electrodes and stimulation devices, turn on the device to produce a proper electric stimulation that the participant can tolerate.

    Sham electro-thumbtack needles (0.25×0.2 mm) which are specially produced have blunt tips instead of sharp needle tip. They will be taped on acupoints of Dazhui (GV14), bilateral Wangu (GB12), bilateral cervical Jiaji (at C4 and C6 level), two Ashi points and bilateral Houxi (SI3) after sterilization. Then apply the gel electrodes and stimulation devices, produce a minimal level of electric stimulation for 30 seconds before turning off the device.

    Outcomes

    Primary Outcome Measures

    Proportion of participants with an at least 50% decrease in NRS-NP from baseline.
    Rate pain intensity by 11 numbers from 0 (no pain at all) to 10 (worst pain imaginable)

    Secondary Outcome Measures

    Change of NRS-NP from baseline.
    Rate pain intensity by 11 numbers from 0 (no pain at all) to 10 (worst pain imaginable)
    Proportion of participants with an at least 50% decrease in NRS-NP from baseline.
    Rate pain intensity by 11 numbers from 0 (no pain at all) to 10 (worst pain imaginable)
    Proportion of participants with an at least 30% decrease in NRS-NP from baseline.
    Rate pain intensity by 11 numbers from 0 (no pain at all) to 10 (worst pain imaginable)
    Change of NPQ from baseline.
    NPQ is a validated questionnaire to learn about the quality and the duration of neck pain and the difficulty coping with chores because of the pain. It contains 9 questions, each ranging from 0 to 4. The total score will be converted to NPQ percentage score (divided by 36 for people who drive and by 32 for those who don't), which ranges from 0 to 100%. High scores indicate worse condition.
    Proportion of participants with an at least 25% decrease in NPQ from baseline and a "better" or "much better" for global effectiveness rating.
    NPQ is a validated questionnaire to learn about the quality and the duration of neck pain and the difficulty coping with chores because of the pain. It contains 9 questions, each ranging from 0 to 4. The total score will be converted to NPQ percentage score (divided by 36 for people who drive and by 32 for those who don't), which ranges from 0 to 100%. High scores indicate worse condition.
    Change of NDI from baseline.
    NDI is a widely used instrument to measure self-reporting disability due to neck pain. It consists of 10 items scored with an ordinal scale from 0-5. The total score ranges from 0-50. Higher scores indicate greater functional limitation. The translated simplified-Chinese version of NDI has been shown to be a responsive and valid measurement for simplified-Chinese speaking patients.
    Proportion of participants with an at least 10-point decrease in NDI from baseline.
    NDI is a widely used instrument to measure self-reporting disability due to neck pain. It consists of 10 items scored with an ordinal scale from 0-5. The total score ranges from 0-50. Higher scores indicate greater functional limitation. The translated simplified-Chinese version of NDI has been shown to be a responsive and valid measurement for simplified-Chinese speaking patients.
    Degree of PGIC.
    Characterize the participants' overall satisfaction and personal feelings about treatment delivery. The options are ranking from "very much worse" to "very much improved" for patients to define their overall status compared with the start of the study.

    Full Information

    First Posted
    July 18, 2021
    Last Updated
    March 24, 2022
    Sponsor
    Shi Hangyu
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT04981171
    Brief Title
    Electro-thumbtack Needle Therapy for Chronic Neck Pain
    Official Title
    Efficacy and Safety of Electro-thumbtack Needle Therapy for Patients With Chronic Neck Pain: a Randomized, Placebo-controlled Trial
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    March 2022
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    April 3, 2022 (Anticipated)
    Primary Completion Date
    December 31, 2023 (Anticipated)
    Study Completion Date
    December 31, 2023 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor-Investigator
    Name of the Sponsor
    Shi Hangyu

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No

    5. Study Description

    Brief Summary
    This prospective trial will be a single-center, participant-blinded, randomized controlled trial. It is reported in previous studies that both acupuncture and transcutaneous electrical nerve stimulation are effective in reducing neck pain comparing to placebo or exercise. Taking into account the convenience of electro-thumbtack needle therapy shown in clinical practice, this study aims to evaluate the efficacy and safety of electro-thumbtack needle therapy for alleviating chronic neck pain compared with sham electro-thumbtack needle therapy.
    Detailed Description
    Chronic neck pain is a commonly experienced symptom that often influences work efficiency and life satisfaction for years. A total of 180 participants suffering mechanical chronic neck pain will be recruited and randomized into either electro-thumbtack needle therapy group or sham electro-thumbtack needle therapy group. All participants will receive the standardized neck exercise instruction at their first treatment session and will be asked to perform the exercise once every day during 4-week treatment. All assessments will be performed by the assessor and the assessment results will be all kept from the acupuncturist. The statistician will be involved in neither assessment nor treatment and will be blinded regarding intervention group code.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Neck Pain

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    ParticipantInvestigatorOutcomes Assessor
    Allocation
    Randomized
    Enrollment
    180 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Electro-thumbtack Needle Therapy (ETN) group
    Arm Type
    Experimental
    Arm Description
    Electro-thumbtack needles (0.25×2 mm) will be inserted into acupoints of Dazhui (GV14), bilateral Wangu (GB12), bilateral cervical Jiaji (at C4 and C6 level), two Ashi points and bilateral Houxi (SI3) after sterilization. Then apply the gel electrodes and stimulation devices, turn on the device to produce a proper electric stimulation that the participant can tolerate.
    Arm Title
    Sham Electro-thumbtack Needle Therapy (ETN) group
    Arm Type
    Sham Comparator
    Arm Description
    Sham electro-thumbtack needles (0.25×0.2 mm) which are specially produced have blunt tips instead of sharp needle tip. They will be taped on acupoints of Dazhui (GV14), bilateral Wangu (GB12), bilateral cervical Jiaji (at C4 and C6 level), two Ashi points and bilateral Houxi (SI3) after sterilization. Then apply the gel electrodes and stimulation devices, produce a minimal level of electric stimulation for 30 seconds before turning off the device.
    Intervention Type
    Procedure
    Intervention Name(s)
    Electro-thumbtack Needle Therapy
    Other Intervention Name(s)
    ETN
    Intervention Description
    Each treatment session starts with sterilizing acupoints. Dazhui (GV14), bilateral Wangu (GB12), bilateral cervical Jiaji (at C4 and C6 level), two Ashi points and bilateral Houxi (SI3) have been selected in accordance with the principle of acupuncture prescription making and the consensus of experts on treating neck pain. Electro-thumbtack needles (0.25×2 mm) will be held by the acupuncturist between thumb and forefinger, vertically inserted into skin instantly and taped well on skin. Then assemble the gel electrodes to the surface of the conductive adhesive tape, also assemble the portable stimulation devices, adjust the current intensity from level 1 to a proper level that the participant can tolerate. Participants will receive three 30-min treatment sessions per week every other day for 4 consecutive weeks.
    Intervention Type
    Procedure
    Intervention Name(s)
    Sham electro-thumbtack needle therapy
    Other Intervention Name(s)
    Sham ETN
    Intervention Description
    Each treatment session starts with sterilizing acupoints. Sham electro-thumbtack needles (0.25×0.2 mm) will be held by the acupuncturist between thumb and forefinger, taped well on skin without penetration. The adhesive tape of needles are also produced with conductive material, after assembling the gel electrodes and the portable stimulation devices, adjust the current intensity to level 1 for a minimal stimulus which will last for only 30 seconds. By this time the acupuncturist will turn the device off to cut the current. Participants will receive three 30-min treatment sessions per week every other day for 4 consecutive weeks.
    Primary Outcome Measure Information:
    Title
    Proportion of participants with an at least 50% decrease in NRS-NP from baseline.
    Description
    Rate pain intensity by 11 numbers from 0 (no pain at all) to 10 (worst pain imaginable)
    Time Frame
    week 4
    Secondary Outcome Measure Information:
    Title
    Change of NRS-NP from baseline.
    Description
    Rate pain intensity by 11 numbers from 0 (no pain at all) to 10 (worst pain imaginable)
    Time Frame
    week 4, 16, 28
    Title
    Proportion of participants with an at least 50% decrease in NRS-NP from baseline.
    Description
    Rate pain intensity by 11 numbers from 0 (no pain at all) to 10 (worst pain imaginable)
    Time Frame
    week 16, 28
    Title
    Proportion of participants with an at least 30% decrease in NRS-NP from baseline.
    Description
    Rate pain intensity by 11 numbers from 0 (no pain at all) to 10 (worst pain imaginable)
    Time Frame
    week 4, 16, 28
    Title
    Change of NPQ from baseline.
    Description
    NPQ is a validated questionnaire to learn about the quality and the duration of neck pain and the difficulty coping with chores because of the pain. It contains 9 questions, each ranging from 0 to 4. The total score will be converted to NPQ percentage score (divided by 36 for people who drive and by 32 for those who don't), which ranges from 0 to 100%. High scores indicate worse condition.
    Time Frame
    week 4, 16, 28
    Title
    Proportion of participants with an at least 25% decrease in NPQ from baseline and a "better" or "much better" for global effectiveness rating.
    Description
    NPQ is a validated questionnaire to learn about the quality and the duration of neck pain and the difficulty coping with chores because of the pain. It contains 9 questions, each ranging from 0 to 4. The total score will be converted to NPQ percentage score (divided by 36 for people who drive and by 32 for those who don't), which ranges from 0 to 100%. High scores indicate worse condition.
    Time Frame
    week 4, 16, 28
    Title
    Change of NDI from baseline.
    Description
    NDI is a widely used instrument to measure self-reporting disability due to neck pain. It consists of 10 items scored with an ordinal scale from 0-5. The total score ranges from 0-50. Higher scores indicate greater functional limitation. The translated simplified-Chinese version of NDI has been shown to be a responsive and valid measurement for simplified-Chinese speaking patients.
    Time Frame
    week 4, 16, 28
    Title
    Proportion of participants with an at least 10-point decrease in NDI from baseline.
    Description
    NDI is a widely used instrument to measure self-reporting disability due to neck pain. It consists of 10 items scored with an ordinal scale from 0-5. The total score ranges from 0-50. Higher scores indicate greater functional limitation. The translated simplified-Chinese version of NDI has been shown to be a responsive and valid measurement for simplified-Chinese speaking patients.
    Time Frame
    week 4, 16, 28
    Title
    Degree of PGIC.
    Description
    Characterize the participants' overall satisfaction and personal feelings about treatment delivery. The options are ranking from "very much worse" to "very much improved" for patients to define their overall status compared with the start of the study.
    Time Frame
    week 4, 28
    Other Pre-specified Outcome Measures:
    Title
    Self-expectation assessment.
    Description
    Participants will be asked "How do you think your neck pain will be after 4 weeks?" for self-expectation, the answers are "worse", "unchanged", "no idea", "better", "much better".
    Time Frame
    baseline
    Title
    Preference of ETN assessment.
    Description
    Participants will be asked"Do you think ETN will be effective for chronic neck pain?" for preference of ETN, the answers are "not effective", "little effective", "not sure", "effective", "very effective".
    Time Frame
    baseline
    Title
    Blinding assessment.
    Description
    All participants will be told before allocation that insertion is deeper in ETN group and shallower in sham ETN group, the electric stimulation is weak or just about to feel in both groups. After treatments finished, they will be asked "Do you think you have received ETN in the past weeks?", the answers are "Yes", "No" or "Unclear".
    Time Frame
    week 4
    Title
    Proportion of participants taking rescue medication.
    Description
    Any other therapy will be discouraged during this trial. If the neck pain occurs heavily or unbearably, acetaminophen (sustained release type, 500 mg/T) will be provided as rescue medication.
    Time Frame
    week 0 to 28
    Title
    Total days of participants demanding rescue medication.
    Description
    Any other therapy will be discouraged during this trial. If the neck pain occurs heavily or unbearably, acetaminophen (sustained release type, 500 mg/T) will be provided as rescue medication.
    Time Frame
    week 0 to 28

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    65 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Diagnosed with neck pain with headaches or neck pain with movement coordination impairments according to the Orthopaedic Section of the American Physical Therapy Association (APTA); Aaged 18-65 years; History of neck pain for at least 3 months; A score of ≥4 in Numerical Rating Scale for neck pain (NRS-NP) assessing the average neck pain intensity over last 7 days until the day of recruitment. Exclusion Criteria: Diagnosed with neck pain with mobility deficits or neck pain with radiating pain according to the Orthopaedic Section, APTA; Known specific reason leading to neck pain such as tumor, immune disease, endocrine and metabolic disorders, neurological abnormalities, cervical vertebra fracture, cervical dislocation; Acute neck pain or neck pain with radiating pain or upper limb symptoms; Neck pain with sensory or motor disturbance; Prior cervical spine surgery or congenital abnormalities; Experiencing medical dispute litigation; Have received acupuncture in last 30 days; In need of analgesic, muscle relaxant, hormones, or bearing greater pain from another area; Allergic to metal or adhesive tape, or carrying cardiac pacemaker, or skin damaged at selected acupoints; Disable to communicate or critically ill; Drug or alcohol dependent; Currently or planning to be pregnant.
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Hangyu Shi
    Phone
    +8618811735839
    Email
    shihangyutcm@163.com
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Hangyu Shi
    Organizational Affiliation
    Guang'anmen Hospital of China Academy of Chinese Medical Sciences
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Citations:
    PubMed Identifier
    35572961
    Citation
    Shi H, Wang X, Yan Y, Zhu L, Chen Y, Gao S, Liu Z. Efficacy and Safety of Electro-Thumbtack Needle Therapy for Patients With Chronic Neck Pain: Protocol for a Randomized, Sham-Controlled Trial. Front Med (Lausanne). 2022 Apr 29;9:872362. doi: 10.3389/fmed.2022.872362. eCollection 2022.
    Results Reference
    derived

    Learn more about this trial

    Electro-thumbtack Needle Therapy for Chronic Neck Pain

    We'll reach out to this number within 24 hrs